Studies a total elbow replacement device in people with elbow joint damage
Tests the Nexel total elbow implant in adults needing elbow replacement surgery.
Key facts
- Who runs it
- Zimmer Biomet
- Where
- Wigan, United KingdomSee the siteAlso in 7 other countries, 10 sites
- Trial code
- Registry title
- Clinical Outcomes Study of the Nexel Total Elbow
- Status
- Recruiting
- People taking part
- 134 people, planned
- Started
- Jun 2015
- Expected to end
- Dec 2036
- Type of study
- Interventional, 2 groups
- Treatments tested
- Nexel Total Elbow
- Record updated
- 9 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who need a first or repeat total elbow replacement because of elbow damage, instability, stiffness or severe arthritis.
- Age
- 18 years or older
- Sex
- All
- Disease stage
- Needs a primary or revision total elbow replacement because of at least one of these: elbow joint destruction that limits daily life, bone loss or injury causing instability, ankylosed (stiff, fused) joints, advanced rheumatoid, post-traumatic or degenerative arthritis with disabling pain, instability or loss of motion, or an acute comminuted fracture of the elbow joint surface.
- Earlier treatment
- People in the retrospective arm must have had a total elbow replacement with the Nexel system between July 2013 and the date of the site initiation visit.
Main reasons for not taking part
- Active or repeated infection at the surgical site, or a major infection elsewhere
- History of prior sepsis
- Paralysis or nerve problems at the elbow, or significant hand dysfunction on the same side
- Heavy labor, torsional stress or competitive sports that may strain the implant
- Known to be pregnant
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Patient is 18 years of age or older
- Patient must have signed Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent
- Patient is a candidate for primary or revision total elbow arthroplasty, based on symptoms including at least one of the following:; Elbow joint destruction which significantly compromises daily living activities; Post-traumatic lesions or bone loss contributing to elbow instability; Ankylosed joints, especially cases of bilateral ankylosis from causes other than active sepsis; Advanced rheumatoid arthritis, post-traumatic, or degenerative arthritis with incapacitating pain; Instability or loss of motion when the degree of joint or soft tissue damage precludes reliable osteosynthesis; Acute comminuted articular fracture of elbow joint surfaces that precludes less radical procedures, including 13-C3 fractures of the distal humerus
- Patient is willing and able to complete scheduled follow-up evaluations as defined by the protocol; Additional Retrospective Arm Inclusion Criteria
- Patient must have undergone a total elbow replacement with the Nexel system between July 2013 and the date of the site initiation visit
- Patient information available for each retrospective patient must, at minimum, include preoperative demographic information, preoperative physical exam information, the index surgery operative report, and details of the devices implanted
Who cannot take part
- Patient has a history of prior sepsis
- Patient has excessive scarring near the surgical site, which could prevent adequate soft tissue coverage
- Patient is a known alcohol or drug abuser
- Patient has a currently active or history of repeated local infection at the surgical site
- Patient has a current major infection distant from the operative site
- Patient suffers from paralysis or dysfunctional neuropathy at the elbow joint
- Patient has significant ipsilateral hand dysfunction
- Patient participates in daily activities that may cause significant stress to an implanted device such as heavy labor, torsional stress, and/or competitive sports
- Patient is a prisoner
- Patient is mentally incompetent or unable to understand what participation in the study entails
- Patient is anticipated to be non-compliant
- Patient is known to be pregnant
Where in United Kingdom
Also in 7 other countries, 10 sites
- WrightingtonWigan, United KingdomContact: Adam Watts, MBBS (principal investigator)Taking people
About the trial
What the trial wants to find out
The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.
The 2 groups in the trial
- RetrospectiveTreatment being tested
Patients who have had primary or revision total elbow arthroplasty using the Nexel Total Elbow, and who have surgical details available
Treatment: Nexel Total Elbow
- ProspectiveTreatment being tested
Patients who are having primary or revision total elbow arthroplasty who will receive the Nexel Total Elbow
Treatment: Nexel Total Elbow
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow
- Plain-language title
- Studies a total elbow replacement device in people with elbow joint damageGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 July 2026